Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Coccidioidomycosis

In brief

The purpose of this study is to determine if nikkomycin Z is safe when administered at different dose levels for 14 days. The study will also determine blood levels and urinary excretion of nikkomycin Z in relation to dose administered. Patients with mild forms of Valley Fever pneumonia will be eligible to participate and will be allocated to receive treatment with nikkomycin Z (various doses) or a placebo. A secondary goal of this study is to evaluate the effectiveness and dose response of nikkomycin Z in an exploratory analysis.

Key facts

Study ID
NCT00614666
Run by
University of Arizona
People needed
6
Starts
2007-09-01
Expected to finish
2009-09-01
Last updated by the study team
2025-04-16

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.